Foundation Medicine Inc (FMI):企業の財務・戦略的SWOT分析

◆英語タイトル:Foundation Medicine Inc (FMI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH254034FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Foundation Medicine Inc (Foundation Medicine) is a molecular information products provider. The company provides molecular information and cancer research programs. It offers clinical products such as FoundationOne for solid tumors and FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and sarcomas; FoundationACT, a blood-based circulating tumor DNA (ctDNA) assay for solid tumor; and FoundationOne CDx, a diagnostic assay for solid tumors. It also provides additional materials, services, and real-time data through its technology products. The company partners with biotech and pharmaceutical companies to develop targeted cancer therapies and active clinical trials. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US.

Foundation Medicine Inc Key Recent Developments

Mar 29,2021: Foundation Medicine Appoints Brian Alexander as Chief Executive Officer
Mar 09,2021: Foundation Medicine and InformedDNA collaborate to improve access to genetic counseling for advanced cancer patients
Jan 19,2021: Foundation Medicine announces executive leadership transition
Nov 17,2020: Leading Diagnostics Companies join forces to establish the access to comprehensive genomic profiling coalition
Oct 07,2020: Foundation Medicine expands research & development operations in San Diego

This comprehensive SWOT profile of Foundation Medicine Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Foundation Medicine Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Foundation Medicine Inc – Key Information
Foundation Medicine Inc – Overview
Foundation Medicine Inc – Key Employees
Foundation Medicine Inc – Key Employee Biographies
Foundation Medicine Inc – Key Operational Heads
Foundation Medicine Inc – Major Products and Services
Foundation Medicine Inc – History
Foundation Medicine Inc – Company Statement
Foundation Medicine Inc – Locations And Subsidiaries
Foundation Medicine Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Foundation Medicine Inc – Business Description
Foundation Medicine Inc – Corporate Strategy
Foundation Medicine Inc – SWOT Analysis
SWOT Analysis – Overview
Foundation Medicine Inc – Strengths
Foundation Medicine Inc – Weaknesses
Foundation Medicine Inc – Opportunities
Foundation Medicine Inc – Threats
Foundation Medicine Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Foundation Medicine Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Foundation Medicine Inc, Key Information
Foundation Medicine Inc, Key Ratios
Foundation Medicine Inc, Share Data
Foundation Medicine Inc, Major Products and Services
Foundation Medicine Inc, History
Foundation Medicine Inc, Key Employees
Foundation Medicine Inc, Key Employee Biographies
Foundation Medicine Inc, Key Operational Heads
Foundation Medicine Inc, Other Locations
Foundation Medicine Inc, Subsidiaries
Foundation Medicine Inc, Key Competitors
Foundation Medicine Inc, SWOT Analysis
Foundation Medicine Inc, Ratios based on current share price
Foundation Medicine Inc, Annual Ratios
Foundation Medicine Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Foundation Medicine Inc (FMI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Valensa International LLC:企業の戦略・SWOT・財務分析
    Valensa International LLC - Strategy, SWOT and Corporate Finance Report Summary Valensa International LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • EarlySense Inc-医療機器分野:企業M&A・提携分析
    Summary EarlySense Inc (EarlySense), a subsidiary of Earlysense Ltd is a medical device company that offers patient care systems. The company offers continuous patient monitoring for heart rate, respiratory rate and motion. It provides central display station, hallway screen, bedside unit, and conta …
  • VirnetX Holding Corp (VHC):企業の財務・戦略的SWOT分析
    Summary VirnetX Holding Corp (VirnetX) is a technology company that provides software and technology solutions for securing real-time communications. The company provides a gabriel connection technology which is an OEM software development kit, and is designed to secure real time communications over …
  • Axel Springer SE:企業の戦略・SWOT・財務情報
    Axel Springer SE - Strategy, SWOT and Corporate Finance Report Summary Axel Springer SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • U.S. Geothermal Inc. (HTM)-エネルギー分野:企業M&A・提携分析
    Summary U.S. Geothermal Inc. (USG) is a renewable energy company. It develops and produces electricity from geothermal source. The company owns and operates geothermal power projects in Oregon, Nevada, and Idaho. USG also has interests in geothermal plants under development or exploration stages in …
  • Zymeworks Inc (ZYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Zymeworks Inc (Zymeworks) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of biotherapeutics for the treatment of cancer, autoimmune and inflammatory diseases. Its pipeline products include ZW25 and ZW49, novel bispecific antibodies …
  • OSE Immunotherapeutics (OSE):企業の財務・戦略的SWOT分析
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • Tanzania Electric Supply Co Ltd:企業の戦略的SWOT分析
    Tanzania Electric Supply Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • CertainTeed Corporation:企業の戦略的SWOT分析
    CertainTeed Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Exact Holding N.V.:企業の戦略的SWOT分析
    Exact Holding N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Schindler Holding Ltd.:戦略・SWOT・企業財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Severn Trent Plc (SVT):企業の財務・戦略的SWOT分析
    Severn Trent Plc (SVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Trimble Solutions Oy:企業の戦略的SWOT分析
    Trimble Solutions Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • America’s Car-Mart, Inc. (CRMT):企業の財務・戦略的SWOT分析
    America's Car-Mart, Inc. (CRMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • AVX Corporation (AVX):企業の財務・戦略的SWOT分析
    AVX Corporation (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Metabolon Inc-医療機器分野:企業M&A・提携分析
    Summary Metabolon Inc (Metabolon) is a health technology company that develops clinical diagnostic tests for healthcare markets. The company’s products include non-alcoholic steatohepatitis test, GFR test, quantose IGT test, prostarix and prostarix plus tests, among others. Its quantose IR test is a …
  • Sagent Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sagent Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • A.S. Watson Group (HK) Limited:企業の戦略・SWOT・財務情報
    A.S. Watson Group (HK) Limited - Strategy, SWOT and Corporate Finance Report Summary A.S. Watson Group (HK) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • OJSC Dixy Group:企業の戦略・SWOT・財務情報
    OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report Summary OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Zydus Wellness Ltd (ZYDUSWELL):企業の財務・戦略的SWOT分析
    Zydus Wellness Ltd (ZYDUSWELL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆